Clinical trial
Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)
NCT00119457 · vTv Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00119457 |
|---|---|
| Title | Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) |
| Official title | A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Weeks Extended VTE Prophylaxis With Daily Oral Doses of TTP889 After One Week of Standard Prophylactic Treatment Following Hip Fracture Surgery |
| Lead sponsor | vTv Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Venous Thromboembolism, Embolism and Thrombosis, Hip Fractures |
| Intervention type | Drug |
| Interventions | TTP889 |
| Enrollment | 300 |
| Start date | Jan 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Jul 13, 2005 |
| Last update posted | Jun 3, 2009 |
| Countries | Czechia, Denmark, Norway, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: